The Noclor partner (named NHS Trust) that has formally declared sponsorship in writing may now be named as the sponsor on applications being made through IRAS (Integrated Research Application System) to the Research Ethics Committee, NHS R&D and Regulatory Authorities as relevant.
The Sponsor Representative is the person authorised by the sponsor organisation to act on the sponsor’s behalf. Noclor has three sponsor representatives that have been delegated authority by its partner Trusts, the Service Director of Research & Development, the Head of Research & Development and the Regulatory Compliance Manager.
The Declaration by Sponsor Representative (IRAS Part D) must be authorised prior to any submissions being made through IRAS. Only authorised representatives of the sponsor can complete the sponsor declaration. Where a Noclor partner has agreed to act a sponsor; for Clinical Trials of Investigational Medicinal Products (CTIMPs) the authorised Sponsor Representative is the Head of R&D and for all other non-CTIMP research the authorised Sponsor Representative is the Regulatory Compliance Manager. Individuals cannot take personal responsibility and research will not be indemnified where the Chief Investigator is named as the sponsor representative.
In signing the declaration the sponsor representative agrees to the organisation being named in the application to act as sponsor for the study and to carry out their duties in relation to the study as set out in the Research Governance Framework for Health and Social Care (and for CTIMPs that the statutory responsibilities of sponsor as set out in the Medicines for Human Use (Clinical Trials) Regulations 2004 SI 1031)).
The details of the sponsor contact (IRAS A-64) should be completed as indicated below.
Noclor Sponsor Representative
INSERT NHS TRUST or CCG NAME here (The Trust organisation for which Noclor is acting on behalf must be named here)
1st Floor, Bloomsbury Building
St Pancras Hospital
4, St Pancras Way
London NW1 0PE
T: 020 3317 3757
F: 020 7685 5788